Linde PlcLIN

Linde plc’s March 2026 10-Q offers a rare sighting of a cash-generative industrial at scale: $8.78bn in revenue from customers, $1.86bn in net income, and $2.44bn in operating income. Earnings per share were $3.98 on 466.3m diluted shares, a figure that would make a dividend chaser pause mid-sip of their oat-based beverage. Cash from operations clocked in at $2.24bn, enough to fund the $1.34bn spent on plant and to leave $3.96bn sitting in the corporate coffers. The balance sheet itself is heavy metal: $86.31bn of assets versus $46.22bn of liabilities, giving shareholders $38.57bn in equity. Inventories crept up $48m to $2.08bn, a detail that might interest only the most obsessive supply-chain analysts-or those who still remember what inflation feels like.

What Linde actually does is sell gases and engineering to industries that cannot take a lunch break: petrochemicals, healthcare, manufacturing, and, increasingly, the hydrogen lobby dreaming of net-zero heat. The company’s clean-energy pages highlight electrolyser technology for green hydrogen, with the International Energy Agency’s Global Hydrogen Review 2022 cited as evidence that global electrolyser capacity could hit 134 GW by 2030. Yet the same quarter that delivered $1.86bn in net profit allocated just $38m to R&D, a figure that sits somewhere between a rounding error and a rounding insult for a company of this scale. The gap between the sustainability slides and the capital-allocation footnote is the real story, not the promise of hydrogen unicorns.

The March 2026 10-Q provides the hard numbers: revenue $8.78bn, net income $1.86bn, operating income $2.44bn, EPS $3.98 on 466.3m diluted shares, operating cash $2.24bn, capex $1.34bn, R&D $38m, inventories $2.08bn with a $48m increase, cash $3.96bn, total assets $86.31bn, total liabilities $46.22bn, equity $38.57bn. (source: LIN 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/1707925/000165495426004202/lin_8k.htm)

If you want a chart, the company’s filings route is over on the SEC’s EDGAR index for Linde plc, but the chart itself is not a crystal ball: it will only show what the market already knows, not what the electrolyser pipeline will deliver in 2030. The hydrogen story is still a promise wrapped in press releases and IEA projections, while the quarterly filings show a mature industrial paying its bills and printing cash-just not at the pace of a venture-backed start-up. The tension is between the slide deck and the ledger, and the ledger is winning so far.

What changed this week: nothing in the filings that alters the quarterly cash-printing narrative. The May 1 2026 8-K restated Q1 2026 results in Exhibit 99.1, a filing habit that suggests Linde prefers ritual to surprise. The June 2026 11-K for Linde Puerto Rico B.V. shows delinquent 401(k) loans of $1.66m, a detail too small to move the stock but large enough to remind readers that even cash-rich companies have administrative gremlins. The green-hydrogen product page remains aspirational, citing the IEA’s 2022 Global Hydrogen Review and glossy images of engineers pointing at turbines. There is still no hard order book for 134 GW of electrolyser capacity, only a projected pipeline.

What remains unproven is whether Linde’s $38m R&D budget can keep pace with the hydrogen hype cycle. The company’s cash generation is stellar, its capital discipline visible in the 10-Q, and its exposure to the energy transition real-but the bridge between today’s cash flow and tomorrow’s green-hydrogen scale is still a set of press releases and a 2030 forecast. If you need deeper proof, look for audited segment-level hydrogen revenue or a capex plan tied to specific electrolyser orders. Until then, the numbers are the story, and the story is that Linde is still very good at making money the old-fashioned way.